Association between Neonatal Phototherapy and Cancer during Childhood

Document Type: Original Article

Authors

1 Department of Pediatrics, Division of Neonatology, School of Medicine, Tehran University of Medical Sciences, Children’s Medical Center, Tehran, Iran

2 Department of Pediatrics, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

10.22038/ijn.2020.42623.1709

Abstract

Background: Phototherapy is the most effective and commonly used treatment for neonatal jaundice, which reduces the need to exchange transfusion. Today, phototherapy is widely used even in unnecessary cases; however, clinicians who use phototherapy should be aware of the possible adverse effects of this treatment to avoid unnecessary use of it. Therefore, this study aimed to evaluate the relationship between neonatal phototherapy and childhood cancer.
Methods: This case-control study assessed 500 children up to 14 years of age with every kind of cancer that referred to Children's Medical Center, Tehran, Iran, during 2015-18. Moreover, 500 children without cancer referring to a General Clinic of Children's Medical Center, Tehran, Iran were included in this study as the control group. History of phototherapy and its duration evaluated in these two groups. Furthermore, demographic characteristics, including maternal age during pregnancy, birth weight, gender, smoking by father, type of cancer, age at cancer detection, and history of cancer in relatives were recorded in this study.
Results: The results of a single-variable logistic regression showed that neonatal phototherapy without any other variables was not significantly correlated with childhood cancer. However, phototherapy will increase the risk of cancer by 55% when it is accompanied by the male gender, maternal age >35 years during pregnancy, and smoking by father.
Conclusion: The potential risk of developing cancer with neonatal phototherapy should be considered versus its benefits in reducing the bilirubin.

Keywords


1. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. NEngl J Med. 2001;344(8): 581-90.
2. Bhutani VK. For a safer outcome with newborn jaundice. Indian Pediatr. 2004;41(4):321-6.
3. MaiselsJM, McDonagh AF.Phototherapy for neonatal jaundice. N Engl J Med. 2008;358(9):920-8.
4. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004; 114(1):e130-53.
5. Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol. 2004;28(5):326-33.
6. XiongT, Qu Y, CambierS,Mu D.The side effects of phototherapy for neonatal jaundice:what do we know? What should we do?Eur J Pediatr.2011; 170(10):1247-55.
7. Podvin D, Kuehn CM, Mueller BA, Williams M. Maternal and birth characteristics in relation to childhood leukemia. PediatrPerinatEpidemiol. 2006; 20(4):312-22.
8. Buffler PA, Kwan ML, Reynolds P, Urayama KY. Environmental and genetic risk factors for childhood leukemia: appraising the evidence.Cancer Invest. 2005; 23(1):60-75.
9. Karadag A, Yesilyurt A, Unal S, Keskin I, Demirin H, Uras N, et al. A chromosomal-effect study of intensive phototherapy versus conventional phototherapy in newborns with jaundice. Mutat Res. 2009;676(1-2):17-20.
10. Yahia S, Shabaan AE, Guida M, El-Ghanam D, Eldegla H, El-Bakary A, et al. Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full-term infants. EurJ Pediatr. 2015;174(4):459-64.
11. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. MolCell Biochem. 2004;266(1-2):37-56.
12. Aycicek A, Kocyigit A, Erel O, Senturk H. Phototherapy causes DNA damage in peripheral mononuclear leukocytes in term infants. J Pediatr. 2008;84(2):141-6.
13. Speck WT, Rosenkranz HS. Phototherapy for neonatal hyperbilirubinemia--a potential environmental health hazard to newborn infants: a review. Environ Mutagen. 1979;1(4):321-36.
14. Ramy N, Ghany E, Alsharany W, Nada A, Darwish R, Rabie W, et al. Jaundice, phototherapy, and DNA damage in full-term neonates. J Perinatol. 2016; 36(2):132-6.
15. Tatli MM, Minnet C, Kocyigit A, Karadag A. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res. 2008; 654(1):93-5.

16. Gathwala G, Sharma S. Phototherapy induces oxidative stress in premature neonates. Indian J Gastroenterol. 2002;21(4):153-4.
17. Kurt A, Aygun AD, Kurt AN, Godekmerdan A, Akarsu S, Yilmaz E. Use of phototherapy for neonatal hyperbilirubinemia affects cytokine
production and lymphocyte subsets. Neonatology. 2009;95(3):262-6.
18. Mesbah-NaminA,Shahidi M,Nakhshab M. An increased genotoxic risk in lymphocytes from phototherapy-treated hyperbilirubinemic neonates. Iran Biomed J. 2017; 21(3):182-9.